Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons
- PMID: 23563516
- PMCID: PMC3903906
- DOI: 10.4161/hv.23090
Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons
Abstract
Background: Since influenza predisposes to bacterial pneumonia caused by Streptococcus pneumoniae, studies have suggested that pneumococcal vaccination might reduce its occurrence during pandemics. We assessed the effectiveness of pneumococcal polysaccharide vaccination alone and in combination with influenza vaccination in preventing influenza hospitalization during the 2009-2010 pandemic wave and 2010-2011 influenza epidemic.
Results: 1187 cases and 2328 controls were included. The adjusted estimate of effectiveness of pneumococcal vaccination in preventing influenza hospitalization was 41% (95% CI 8-62) in all patients and 43% (95% CI 2-78) in patients aged ≥ 65 y. The adjusted effectiveness of dual PPV23 and influenza vaccination was 81% (95% CI 65-90) in all patients and 76% (95% CI 46-90) in patients aged ≥ 65 y. The adjusted effectiveness of influenza vaccination alone was 58% (95% CI 38-72).
Methods: We conducted a multicenter case-control study in 36 Spanish hospitals. We selected patients aged ≥ 18 y hospitalized with confirmed influenza and two hospitalized controls per case, matched according to age, date of hospitalization and province of residence. Multivariate analysis was performed using conditional logistic regression. Subjects were considered vaccinated if they had received the pneumococcal or seasonal influenza vaccine>14 d (or>7 d for pandemic influenza vaccine) before the onset of symptoms (cases) or the onset of symptoms in matched cases (controls).
Conclusions: In elderly people and adults with chronic illness, pneumococcal vaccination may reduce hospitalizations during the influenza season. In people vaccinated with both the influenza and pneumococcal vaccines, the benefit in hospitalizations avoided was greater than in those vaccinated only against influenza.
Keywords: effectiveness; hospitalization; influenza vaccine; laboratory-confirmed influenza; pneumococcal polysaccharide vaccine.
Figures
Similar articles
-
Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.Vaccine. 2017 Aug 24;35(36):4806-4810. doi: 10.1016/j.vaccine.2017.07.005. Vaccine. 2017. PMID: 28818473
-
Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study.Pediatr Infect Dis J. 2013 Apr;32(4):330-4. doi: 10.1097/INF.0b013e318280a34b. Pediatr Infect Dis J. 2013. PMID: 23337901
-
Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.Vaccine. 2012 Aug 17;30(38):5644-50. doi: 10.1016/j.vaccine.2012.06.090. Epub 2012 Jul 10. Vaccine. 2012. PMID: 22796136
-
Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis.Expert Rev Vaccines. 2018 Jul;17(7):653-663. doi: 10.1080/14760584.2018.1495077. Epub 2018 Jul 16. Expert Rev Vaccines. 2018. PMID: 29961353 Review.
-
[Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].Semergen. 2016 Oct;42(7):464-475. doi: 10.1016/j.semerg.2016.07.009. Epub 2016 Sep 15. Semergen. 2016. PMID: 27641310 Spanish.
Cited by
-
Factors associated with pneumococcal vaccination among an urban elderly population in China.Hum Vaccin Immunother. 2014;10(10):2994-9. doi: 10.4161/21645515.2014.972155. Hum Vaccin Immunother. 2014. PMID: 25483646 Free PMC article.
-
Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Streptococcus pneumoniae Challenge during Influenza A Infection.Vaccines (Basel). 2019 Oct 11;7(4):146. doi: 10.3390/vaccines7040146. Vaccines (Basel). 2019. PMID: 31614565 Free PMC article.
-
Hospital admission trends due to respiratory diseases in England and Wales between 1999 and 2019: an ecologic study.BMC Pulm Med. 2021 Nov 8;21(1):356. doi: 10.1186/s12890-021-01736-8. BMC Pulm Med. 2021. PMID: 34749696 Free PMC article.
-
The full benefits of adult pneumococcal vaccination: A systematic review.PLoS One. 2017 Oct 31;12(10):e0186903. doi: 10.1371/journal.pone.0186903. eCollection 2017. PLoS One. 2017. PMID: 29088258 Free PMC article.
-
Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization.Clin Vaccine Immunol. 2015 Feb;22(2):229-34. doi: 10.1128/CVI.00673-14. Epub 2014 Dec 24. Clin Vaccine Immunol. 2015. PMID: 25540271 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400–2. - PubMed
-
- Red Nacional de Vigilancia Epidemiológica. Vigilancia de la gripe en España. Temporada 2010-2011. Available at: http://vgripe.isciii.es/gripe Accessed on September 15, 2012.
-
- WHO Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec. 2010;85:81–92. - PubMed
-
- Walter ND, Taylor TH, Shay DK, Thompson WW, Brammer L, Dowell SF, et al. Active Bacterial Core Surveillance Team Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis. 2010;50:175–83. doi: 10.1086/649208. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical